APA (7th ed.) Citation

E, M., R, D., N, D., J, L., R, M., J, M., . . . JM, M. (2023). Liver lipopolysaccharide binding protein prevents hepatic inflammation in physiological and pathological non-obesogenic conditions. Pharmacological research, 187, 106562. https://doi.org/10.1016/j.phrs.2022.106562

Chicago Style (17th ed.) Citation

E, Milbank, et al. "Liver Lipopolysaccharide Binding Protein Prevents Hepatic Inflammation in Physiological and Pathological Non-obesogenic Conditions." Pharmacological Research 187 (2023): 106562. https://doi.org/10.1016/j.phrs.2022.106562.

MLA (9th ed.) Citation

E, Milbank, et al. "Liver Lipopolysaccharide Binding Protein Prevents Hepatic Inflammation in Physiological and Pathological Non-obesogenic Conditions." Pharmacological Research, vol. 187, 2023, p. 106562, https://doi.org/10.1016/j.phrs.2022.106562.